Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 50 of 621

    1.

    Blood stem cell transplantation in older patients.

    Murphy WJ, Artz AS, Champlin RE, Koreth J, Longo DL.

    Biol Blood Marrow Transplant. 2009 Dec;15(12):1638-9.PMID: 19911448 [PubMed - in process]Related articles

    2.

    <i>piggyBac</i> transposon/transposase system to generate CD19-specific T cells for treatment of B-lineage malignancies.

    Raja Manuri PV, Wilson MH, Maiti SN, Mi T, Singh H, Olivares S, Dawson MJ, Huls H, Lee DA, Rao PH, Kaminski JM, Nakazawa Y, Gottschalk S, Kebriaei P, Shpall EJ, Champlin RE, Cooper LJ.

    Hum Gene Ther. 2009 Nov 11. [Epub ahead of print]PMID: 19905893 [PubMed - as supplied by publisher]Related articles

    3.

    A phase III study of infliximab and corticosteroids for the initial treatment of acute graft-versus-host disease.

    Couriel DR, Saliba R, de Lima M, Giralt S, Andersson B, Khouri I, Hosing C, Ippoliti C, Shpall EJ, Champlin R, Alousi A.

    Biol Blood Marrow Transplant. 2009 Dec;15(12):1555-62. Epub 2009 Sep 25.PMID: 19896079 [PubMed - in process]Related articles

    4.

    Blocking LFA-1 activation with lovastatin prevents graft-versus-host disease in mouse bone marrow transplantation.

    Wang Y, Li D, Jones D, Bassett R, Sale GE, Khalili J, Komanduri KV, Couriel DR, Champlin RE, Molldrem JJ, Ma Q.

    Biol Blood Marrow Transplant. 2009 Dec;15(12):1513-22. Epub 2009 Oct 7.PMID: 19896074 [PubMed - in process]Related articles

    5.

    High risk of graft failure in patients with anti-HLA antibodies undergoing haploidentical stem-cell transplantation.

    Ciurea SO, de Lima M, Cano P, Korbling M, Giralt S, Shpall EJ, Wang X, Thall PF, Champlin RE, Fernandez-Vina M.

    Transplantation. 2009 Oct 27;88(8):1019-24.PMID: 19855248 [PubMed - in process]Related articles

    6.

    CD3(+) and/or CD14(+) depletion from cord blood mononuclear cells before ex vivo expansion culture improves total nucleated cell and CD34(+) cell yields.

    Yang H, Robinson SN, Lu J, Decker WK, Xing D, Steiner D, Parmar S, Shah N, Champlin RE, Munsell M, Leen A, Bollard C, Simmons PJ, Shpall EJ.

    Bone Marrow Transplant. 2009 Oct 19. [Epub ahead of print]PMID: 19838220 [PubMed - as supplied by publisher]Related articles

    7.

    Receiving information on fertility- and menopause-related treatment effects among women who undergo hematopoietic stem cell transplantation: changes in perceived importance over time.

    Nakayama K, Liu P, Detry M, Schover LR, Milbourne A, Neumann J, Rondon G, Thewes B, Champlin RE, Ueno NT.

    Biol Blood Marrow Transplant. 2009 Nov;15(11):1465-74.PMID: 19822307 [PubMed - in process]Related articles

    8.

    Impact of pre-transplant rituximab on survival after autologous hematopoietic stem cell transplantation for diffuse large B cell lymphoma.

    Fenske TS, Hari PN, Carreras J, Zhang MJ, Kamble RT, Bolwell BJ, Cairo MS, Champlin RE, Chen YB, Freytes CO, Gale RP, Hale GA, Ilhan O, Khoury HJ, Lister J, Maharaj D, Marks DI, Munker R, Pecora AL, Rowlings PA, Shea TC, Stiff P, Wiernik PH, Winter JN, Rizzo JD, van Besien K, Lazarus HM, Vose JM.

    Biol Blood Marrow Transplant. 2009 Nov;15(11):1455-64.PMID: 19822306 [PubMed - in process]Related articles

    9.

    Quantifying the survival benefit for allogeneic hematopoietic stem cell transplantation in relapsed acute myelogenous leukemia.

    Armistead PM, de Lima M, Pierce S, Qiao W, Wang X, Thall PF, Giralt S, Ravandi F, Kantarjian H, Champlin R, Estey E.

    Biol Blood Marrow Transplant. 2009 Nov;15(11):1431-8. Epub 2009 Sep 1.PMID: 19822303 [PubMed - in process]Related articles

    10.

    The Effect of the Composition of Unrelated Donor Bone Marrow and Peripheral Blood Progenitor Cell Grafts on Transplantation Outcomes.

    Collins NH, Gee AP, Durett AG, Kan F, Zhang MJ, Champlin RE, Confer D, Eapen M, Howard A, King R, Laughlin MJ, Plante RJ, Setterholm M, Spellman S, Keever-Taylor C, Wagner JE, Weisdorf DJ.

    Biol Blood Marrow Transplant. 2009 Oct 9. [Epub ahead of print]PMID: 19822219 [PubMed - as supplied by publisher]Related articles

    11.

    Nonmyeloablative allogeneic stem cell transplantation for chronic myelogenous leukemia in the imatinib era.

    Champlin R, de Lima M, Kebriaei P, Rondon G, Fisher T, Jabbour E, Cortés JE, Kantarjian H, Anderlini P, Alousi A, Hosing C, Shpall E, Popat U, Qazilbash M, Andersson B, Giralt S.

    Clin Lymphoma Myeloma. 2009;9 Suppl 3:S261-5.PMID: 19778850 [PubMed - in process]Related articles

    12.

    Course of cognitive decline in hematopoietic stem cell transplantation: a within-subjects design.

    Friedman MA, Fernandez M, Wefel JS, Myszka KA, Champlin RE, Meyers CA.

    Arch Clin Neuropsychol. 2009 Nov;24(7):689-98. Epub 2009 Sep 18.PMID: 19767298 [PubMed - in process]Related articles

    13.

    Outcome of allogeneic hematopoietic stem cell transplantation in patients with low left ventricular ejection fraction.

    Qazilbash MH, Amjad AI, Qureshi S, Qureshi SR, Saliba RM, Khan ZU, Hosing C, Giralt SA, De Lima MJ, Popat UR, Yusuf SW, Champlin RE.

    Biol Blood Marrow Transplant. 2009 Oct;15(10):1265-70. Epub 2009 Aug 3.PMID: 19747634 [PubMed - in process]Related articles

    14.

    5-Aza-2'-deoxycytidine sensitizes busulfan-resistant myeloid leukemia cells by regulating expression of genes involved in cell cycle checkpoint and apoptosis.

    Valdez BC, Li Y, Murray D, Corn P, Champlin RE, Andersson BS.

    Leuk Res. 2009 Sep 2. [Epub ahead of print]PMID: 19732952 [PubMed - as supplied by publisher]Related articles

    15.

    Utility of early versus late fiberoptic bronchoscopy in the evaluation of new pulmonary infiltrates following hematopoietic stem cell transplantation.

    Shannon VR, Andersson BS, Lei X, Champlin RE, Kontoyiannis DP.

    Bone Marrow Transplant. 2009 Aug 17. [Epub ahead of print]PMID: 19684637 [PubMed - as supplied by publisher]Related articles

    16.

    Reduced-intensity conditioning using fludarabine, melphalan and thiotepa for adult patients undergoing haploidentical SCT.

    Ciurea SO, Saliba R, Rondon G, Pesoa S, Cano P, Fernandez-Vina M, Qureshi S, Worth LL, McMannis J, Kebriaei P, Jones RB, Korbling M, Qazilbash M, Shpall EJ, Giralt S, Lima MD, Champlin RE, Gajewski J.

    Bone Marrow Transplant. 2009 Aug 10. [Epub ahead of print]PMID: 19668237 [PubMed - as supplied by publisher]Related articles

    17.

    Pilot study of targeted skeletal radiation therapy for bone-only metastatic breast cancer.

    Ueno NT, de Souza JA, Booser D, Nakayama K, Madewell J, Wendt RE 3rd, Hortobagyi GN, Podoloff D, Champlin RE.

    Clin Breast Cancer. 2009 Aug;9(3):173-7.PMID: 19661041 [PubMed - indexed for MEDLINE]Related articles

    18.

    Moderate renal function impairment does not affect outcomes of reduced-intensity conditioning with fludarabine and melphalan for allogeneic hematopoietic stem cell transplantation.

    de Souza JA, Saliba RM, Patah P, Rondon G, Ribeiro R, de Padua Silva L, Qazilbash MH, Hosing C, Popat U, Efebera Y, Champlin RE, de Lima M.

    Biol Blood Marrow Transplant. 2009 Sep;15(9):1094-9.PMID: 19660722 [PubMed - indexed for MEDLINE]Related articles

    19.

    Donor-recipient mismatches in MHC class I chain-related gene A in unrelated donor transplantation lead to increased incidence of acute graft-versus-host disease.

    Parmar S, Del Lima M, Zou Y, Patah PA, Liu P, Cano P, Rondon G, Pesoa S, de Padua Silva L, Qazilbash MH, Hosing C, Popat U, Kebriaei P, Shpall EJ, Giralt S, Champlin RE, Stastny P, Fernandez-Vina M.

    Blood. 2009 Oct 1;114(14):2884-7. Epub 2009 Aug 4.PMID: 19654407 [PubMed - in process]Related articles

    20.

    Reduced-toxicity conditioning therapy with allogeneic stem cell transplantation for acute leukemia.

    Andersson BS, de Lima M, Thall PF, Madden T, Russell JA, Champlin RE.

    Curr Opin Oncol. 2009 Jun;21 Suppl 1:S11-5.PMID: 19561406 [PubMed - indexed for MEDLINE]Related articles

    21.

    Infections in non-myeloablative hematopoietic stem cell transplantation patients with lymphoid malignancies: spectrum of infections, predictors of outcome and proposed guidelines for fungal infection prevention.

    Safdar A, Rodriguez GH, Mihu CN, Mora-Ramos L, Mulanovich V, Chemaly RF, Champlin RE, Khouri I.

    Bone Marrow Transplant. 2009 Jun 29. [Epub ahead of print]PMID: 19561648 [PubMed - as supplied by publisher]Related articles

    22.

    Autologous hematopoietic stem cell transplantation may reverse renal failure in patients with multiple myeloma.

    Parikh GC, Amjad AI, Saliba RM, Kazmi SM, Khan ZU, Lahoti A, Hosing C, Mendoza F, Qureshi SR, Weber DM, Wang M, Popat U, Alousi AM, Champlin RE, Giralt SA, Qazilbash MH.

    Biol Blood Marrow Transplant. 2009 Jul;15(7):812-6.PMID: 19539212 [PubMed - indexed for MEDLINE]Related articles

    23.

    Impairment of filgrastim-induced stem cell mobilization after prior lenalidomide in patients with multiple myeloma.

    Popat U, Saliba R, Thandi R, Hosing C, Qazilbash M, Anderlini P, Shpall E, McMannis J, Körbling M, Alousi A, Andersson B, Nieto Y, Kebriaei P, Khouri I, de Lima M, Weber D, Thomas S, Wang M, Jones R, Champlin R, Giralt S.

    Biol Blood Marrow Transplant. 2009 Jun;15(6):718-23. Epub 2009 Apr 8.PMID: 19450756 [PubMed - indexed for MEDLINE]Related articles

    24.

    Prolonged disease control by nonmyeloablative allogeneic transplantation for metastatic breast cancer.

    de Souza JA, Davis ML, Rondon G, Cheng YC, Jones RB, Champlin RE, Ueno NT.

    Bone Marrow Transplant. 2009 Jul;44(2):81-7. Epub 2009 May 18.PMID: 19448681 [PubMed - in process]Related articles

    25.

    Poor hematopoietic stem cell mobilizers: a single institution study of incidence and risk factors in patients with recurrent or relapsed lymphoma.

    Hosing C, Saliba RM, Ahlawat S, Körbling M, Kebriaei P, Alousi A, De Lima M, Okoroji JG, McMannis J, Qazilbash M, Anderlini P, Giralt S, Champlin RE, Khouri I, Popat U.

    Am J Hematol. 2009 Jun;84(6):335-7.PMID: 19384931 [PubMed - indexed for MEDLINE]Related articles

    26.

    Rapid transport and infusion of hematopoietic cells is associated with improved outcome after myeloablative therapy and unrelated donor transplant.

    Lazarus HM, Kan F, Tarima S, Champlin RE, Confer DL, Frey N, Gee AP, Wagner JE, Horowitz MM, Eapen M.

    Biol Blood Marrow Transplant. 2009 May;15(5):589-96.PMID: 19361751 [PubMed - indexed for MEDLINE]Related articles

    27.

    Unrelated donor hematopoietic cell transplantation for non-hodgkin lymphoma: long-term outcomes.

    van Besien K, Carreras J, Bierman PJ, Logan BR, Molina A, King R, Nelson G, Fay JW, Champlin RE, Lazarus HM, Vose JM, Hari PN.

    Biol Blood Marrow Transplant. 2009 May;15(5):554-63. Epub 2009 Mar 9.PMID: 19361747 [PubMed - indexed for MEDLINE]Related articles

    28.

    Hepatosplenic gamma-delta T-cell lymphoma: clinicopathological features and treatment.

    Falchook GS, Vega F, Dang NH, Samaniego F, Rodriguez MA, Champlin RE, Hosing C, Verstovsek S, Pro B.

    Ann Oncol. 2009 Jun;20(6):1080-5. Epub 2009 Feb 23.PMID: 19237479 [PubMed - indexed for MEDLINE]Related articles

    29.

    Low-dose azacitidine after allogeneic stem cell transplantation for acute leukemia.

    Jabbour E, Giralt S, Kantarjian H, Garcia-Manero G, Jagasia M, Kebriaei P, de Padua L, Shpall EJ, Champlin R, de Lima M.

    Cancer. 2009 May 1;115(9):1899-905.PMID: 19235255 [PubMed - indexed for MEDLINE]Related articles

    30.

    Mature results of the M. D. Anderson Cancer Center risk-adapted transplantation strategy in mantle cell lymphoma.

    Tam CS, Bassett R, Ledesma C, Korbling M, Alousi A, Hosing C, Kebraei P, Harrell R, Rondon G, Giralt SA, Anderlini P, Popat U, Pro B, Samuels B, Hagemeister F, Medeiros LJ, Champlin RE, Khouri IF.

    Blood. 2009 Apr 30;113(18):4144-52. Epub 2009 Jan 23.PMID: 19168784 [PubMed - indexed for MEDLINE]Related articles

    31.

    Feasibility of allo-SCT after hypomethylating therapy with decitabine for myelodysplastic syndrome.

    De Padua Silva L, de Lima M, Kantarjian H, Faderl S, Kebriaei P, Giralt S, Davisson J, Garcia-Manero G, Champlin R, Issa JP, Ravandi F.

    Bone Marrow Transplant. 2009 Jun;43(11):839-43. Epub 2009 Jan 19.PMID: 19151791 [PubMed - indexed for MEDLINE]Related articles

    32.

    Impact of hepatitis C virus seropositivity on survival after allogeneic hematopoietic stem cell transplantation for hematologic malignancies.

    Ramos CA, Saliba RM, de Pádua L, Khorshid O, Shpall EJ, Giralt S, Patah PA, Hosing CM, Popat UR, Rondon G, Khouri IF, Nieto YL, Champlin RE, de Lima M.

    Haematologica. 2009 Feb;94(2):249-57. Epub 2009 Jan 14.PMID: 19144658 [PubMed - indexed for MEDLINE]Related articlesFree article

    33.

    Arsenic trioxide with ascorbic acid and high-dose melphalan: results of a phase II randomized trial.

    Qazilbash MH, Saliba RM, Nieto Y, Parikh G, Pelosini M, Khan FB, Jones RB, Hosing C, Mendoza F, Weber DM, Wang M, Popat U, Alousi A, Anderlini P, Champlin RE, Giralt S.

    Biol Blood Marrow Transplant. 2008 Dec;14(12):1401-7.PMID: 19041063 [PubMed - indexed for MEDLINE]Related articles

    34.

    Leukemia burden delays lymphocyte and platelet recovery after allo-SCT for AML.

    Saliba RM, Komanduri KV, Giralt S, de Souza J, Patah P, Oran B, Couriel D, Rondon G, Champlin RE, de Lima M.

    Bone Marrow Transplant. 2009 May;43(9):685-92. Epub 2008 Nov 17.PMID: 19011667 [PubMed - indexed for MEDLINE]Related articles

    35.

    Variation in supportive care practices in hematopoietic cell transplantation.

    Lee SJ, Astigarraga CC, Eapen M, Artz AS, Davies SM, Champlin R, Jagasia M, Kernan NA, Loberiza FR Jr, Bevans M, Soiffer RJ, Joffe S.

    Biol Blood Marrow Transplant. 2008 Nov;14(11):1231-8.PMID: 18940677 [PubMed - indexed for MEDLINE]Related articles

    36.

    PET imaging of T cells derived from umbilical cord blood.

    Singh H, Najjar AM, Olivares S, Nishii R, Mukhopadhyay U, Alauddin M, Manuri PR, Huls H, Lee DA, Dotti G, Bollard C, Simmons PJ, Shpall EJ, Champlin RE, Gelovani JG, Cooper LJ.

    Leukemia. 2009 Mar;23(3):620-2. Epub 2008 Oct 2. No abstract available. PMID: 18830258 [PubMed - indexed for MEDLINE]Related articles

    37.

    Impact of prior imatinib mesylate on the outcome of hematopoietic cell transplantation for chronic myeloid leukemia.

    Lee SJ, Kukreja M, Wang T, Giralt SA, Szer J, Arora M, Woolfrey AE, Cervantes F, Champlin RE, Gale RP, Halter J, Keating A, Marks DI, McCarthy PL, Olavarria E, Stadtmauer EA, Abecasis M, Gupta V, Khoury HJ, George B, Hale GA, Liesveld JL, Rizzieri DA, Antin JH, Bolwell BJ, Carabasi MH, Copelan E, Ilhan O, Litzow MR, Schouten HC, Zander AR, Horowitz MM, Maziarz RT.

    Blood. 2008 Oct 15;112(8):3500-7. Epub 2008 Jul 29.PMID: 18664621 [PubMed - indexed for MEDLINE]Related articlesFree article

    38.

    Long-term follow-up of patients who experienced graft failure postallogeneic progenitor cell transplantation. Results of a single institution analysis.

    Rondón G, Saliba RM, Khouri I, Giralt S, Chan K, Jabbour E, McMannis J, Champlin R, Shpall E.

    Biol Blood Marrow Transplant. 2008 Aug;14(8):859-66.PMID: 18640568 [PubMed - indexed for MEDLINE]Related articles

    39.

    The natural history and treatment outcome of blast phase BCR-ABL- myeloproliferative neoplasms.

    Tam CS, Nussenzveig RM, Popat U, Bueso-Ramos CE, Thomas DA, Cortes JA, Champlin RE, Ciurea SE, Manshouri T, Pierce SM, Kantarjian HM, Verstovsek S.

    Blood. 2008 Sep 1;112(5):1628-37. Epub 2008 Jun 19.PMID: 18566326 [PubMed - indexed for MEDLINE]Related articlesFree article

    40.

    Disease staging with positron emission tomography or gallium scanning and use of rituximab predict outcome for patients with diffuse large B-cell lymphoma treated with autologous stem cell transplantation.

    Alousi AM, Saliba RM, Okoroji GJ, Macapinlac HA, Hosing C, Korbling M, Samuels BI, Popat U, Kebriaei P, Anderlini P, Qazilbash MH, de Lima M, Giralt SA, Champlin RE, Khouri IF.

    Br J Haematol. 2008 Sep;142(5):786-92. Epub 2008 Jun 17.PMID: 18564354 [PubMed - indexed for MEDLINE]Related articles

    41.

    Once daily i.v. busulfan and fludarabine (i.v. Bu-Flu) compares favorably with i.v. busulfan and cyclophosphamide (i.v. BuCy2) as pretransplant conditioning therapy in AML/MDS.

    Andersson BS, de Lima M, Thall PF, Wang X, Couriel D, Korbling M, Roberson S, Giralt S, Pierre B, Russell JA, Shpall EJ, Jones RB, Champlin RE.

    Biol Blood Marrow Transplant. 2008 Jun;14(6):672-84.PMID: 18489993 [PubMed - indexed for MEDLINE]Related articles

    42.

    Redirecting specificity of T-cell populations for CD19 using the Sleeping Beauty system.

    Singh H, Manuri PR, Olivares S, Dara N, Dawson MJ, Huls H, Hackett PB, Kohn DB, Shpall EJ, Champlin RE, Cooper LJ.

    Cancer Res. 2008 Apr 15;68(8):2961-71.PMID: 18413766 [PubMed - indexed for MEDLINE]Related articlesFree article

    43.

    Eight-year experience with allogeneic stem cell transplantation for relapsed follicular lymphoma after nonmyeloablative conditioning with fludarabine, cyclophosphamide, and rituximab.

    Khouri IF, McLaughlin P, Saliba RM, Hosing C, Korbling M, Lee MS, Medeiros LJ, Fayad L, Samaniego F, Alousi A, Anderlini P, Couriel D, de Lima M, Giralt S, Neelapu SS, Ueno NT, Samuels BI, Hagemeister F, Kwak LW, Champlin RE.

    Blood. 2008 Jun 15;111(12):5530-6. Epub 2008 Apr 14. Erratum in: Blood. 2009 Feb 12;113(7):1613. PMID: 18411419 [PubMed - indexed for MEDLINE]Related articlesFree article

    44.

    Individual physician practice variation in hematopoietic cell transplantation.

    Lee SJ, Joffe S, Artz AS, Champlin RE, Davies SM, Jagasia M, Kernan NA, Loberiza FR Jr, Soiffer RJ, Eapen M.

    J Clin Oncol. 2008 May 1;26(13):2162-70. Epub 2008 Mar 31.PMID: 18378566 [PubMed - indexed for MEDLINE]Related articles

    45.

    Rituximab for passenger lymphocyte syndrome associated with allogeneic SCT.

    Lee HJ, Gulbis A, De Padua Silva L, Hosing C, Khouri I, de Lima M, Champlin RE, Ciurea SO.

    Bone Marrow Transplant. 2008 Jul;42(1):67-9. Epub 2008 Mar 17. Review. No abstract available. PMID: 18347568 [PubMed - indexed for MEDLINE]Related articles

    46.

    Evidence of a graft-versus-Hodgkin lymphoma effect in the setting of extensive bone marrow involvement.

    Anderlini P, Swanston N, Rashid A, Bueso-Ramos C, Macapinlac HA, Champlin RE.

    Biol Blood Marrow Transplant. 2008 Apr;14(4):478-80. Epub 2008 Feb 14. No abstract available. PMID: 18342791 [PubMed - indexed for MEDLINE]Related articles

    47.

    Altered gene expression in busulfan-resistant human myeloid leukemia.

    Valdez BC, Murray D, Ramdas L, de Lima M, Jones R, Kornblau S, Betancourt D, Li Y, Champlin RE, Andersson BS.

    Leuk Res. 2008 Nov;32(11):1684-97. Epub 2008 Mar 12.PMID: 18339423 [PubMed - indexed for MEDLINE]Related articlesFree article

    48.

    Peripheral blood progenitor cell or bone marrow transplantation: controversy remains.

    Koca E, Champlin RE.

    Curr Opin Oncol. 2008 Mar;20(2):220-6. Review.PMID: 18300773 [PubMed - indexed for MEDLINE]Related articles

    49.

    High-dose chemotherapy and autologous hematopoietic progenitor cell transplantation for non-Hodgkin's lymphoma in patients >65 years of age.

    Hosing C, Saliba RM, Okoroji GJ, Popat U, Couriel D, Ali T, De Padua Silva L, Kebriaei P, Alousi A, De Lima M, Qazilbash M, Anderlini P, Giralt S, Champlin RE, Khouri I.

    Ann Oncol. 2008 Jun;19(6):1166-71. Epub 2008 Feb 13.PMID: 18272911 [PubMed - indexed for MEDLINE]Related articlesFree article

    50.

    Gonadal failure after treatment of hematologic malignancies: from recognition to management for health-care providers.

    Nakayama K, Milbourne A, Schover LR, Champlin RE, Ueno NT.

    Nat Clin Pract Oncol. 2008 Feb;5(2):78-89. Review.PMID: 18235440 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data

    Search details

    » See more...